Frequent down-regulation of HIVEP2 in human breast cancer Hiroaki FujiiEdward GabrielsonOkio Hino Report Pages: 103 - 112
An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement Emmanuel BarrangerCharles CoutantSerge Uzan Report Pages: 113 - 119
Estimating the number of rate limiting genomic changes for human breast cancer Xinan ZhangRichard Simon Report Pages: 121 - 124
Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer Yasushi NakamuraHironao YasuokaKennichi Kakudo Report Pages: 125 - 132
Characterization of a human breast cancer cell line, MCF-7/RU58R-1, resistant to the pure antiestrogen RU 58,668 C. K. FogI. J. ChristensenA. E. Lykkesfeldt Report Pages: 133 - 144
Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance Marie AhnströmBo NordenskjöldOlle Stål Report Pages: 145 - 151
Economic outcomes of breast cancer survivorship: CALGB study 79804 Martee L. HensleyJeannette DowellElectra Paskett Report Pages: 153 - 161
Immune dysfunction and micrometastases in women with breast cancer Michael J. CampbellJanet ScottLaura J. Esserman Report Pages: 163 - 171
Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expression P. J. BarnesR. BoutilierD. Rayson Report Pages: 173 - 178
BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles Evan MatrosZhigang C. WangAndrea L. Richardson Report Pages: 179 - 186
Differential sensitivities of trastuzumab (Herceptin®)-resistant human breast cancer cells to phosphoinositide-3 kinase (PI-3K) and epidermal growth factor receptor (EGFR) kinase inhibitors Carmel T. ChanMarianne Z. MetzSusan E. Kane Report Pages: 187 - 201
A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes Antonino MusolinoNadia NaldiAndrea Ardizzoni Brief communication Pages: 203 - 205
